LMN-201 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-08-31 in 25d
ESTIMATED |
READOUT
LMN-201 for Prevention of C. Difficile Infection Recurrence
Phase 2/3 · Clostridioides Difficile Infection |
Lumen Bioscience, Inc. | LMN-201 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|